查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1607171

基因组市场：按技术、产品、应用和最终用户划分 - 全球预测 2025-2030

Gene Panel Market by Technique (Microarray, Next-Generation Sequencing, Polymerase Chain Reaction), Product (Test Kits, Testing Services), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年基因面板市值为31.1亿美元，预计2024年将达到34.1亿美元，复合年增长率为9.99%，到2030年将达到60.6亿美元。

基因组是使用次世代定序仪技术同时测试的基因的集合。这对于识别与各种疾病相关的基因突变以及准确和个人化的医疗至关重要。对基因组的需求源于其提供快速、全面的遗传洞察并提高诊断准确性和治疗个性化的能力。其应用涵盖多个领域，包括肿瘤学以促进突变检测以进行标靶治疗和遗传疾病以进行早期诊断。在最终使用场景中，基因组在临床诊断、研究机构和医院中至关重要，尤其是在肿瘤学和罕见疾病领域。

主要市场统计
基准年[2023] 31.1亿美元
预测年份 [2024] 34.1亿美元
预测年份 [2030] 60.6亿美元
复合年增长率（%） 9.99%

市场成长受到个人化医疗需求不断增长、定序技术进步和研究经费增加的影响。遗传疾病和癌症的日益普及增加了对基因组等有效诊断工具的需求。最新的机会在于开发检测更广泛基因并提高准确性和速度的面板。随着人们对个人基因组学认识的提高，对直接面向消费者的基因检测的兴趣激增。对公司的建议包括投资扩大基因组的范围以涵盖更多罕见疾病，并与医疗保健提供者合作将测试纳入日常实践。

然而，测试成本上升、资料解释复杂和监管环境等挑战正在阻碍市场成长。遗传资料的复杂性需要熟练的人员，而不同地区监管标准的差异可能会阻碍全球市场的扩张。业务成长的创新领域包括开发具有成本效益的综合面板以及在资料分析中采用人工智慧来简化解释过程。公司可以专注于创建不仅针对引起疾病的突变，还针对药物基因组学的面板，以实现更好的药物反应，从而强化个人化医疗趋势。此外，扩大与生物技术公司和学术研究机构的伙伴关係可以有效推动进步和市场扩张。您还可以透过主动回应并领先于监管变化来提高竞争力。

市场动态：揭示快速发展的基因面板市场的关键市场洞察

供需的动态交互作用正在改变基因组市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 遗传疾病和罕见疾病迅速增加
    • 对个人化药物的需求不断增长
    • 多基因面板测试在癌症治疗中的快速普及
  • 市场限制因素
    • 确保遗传资料安全的问题
  • 市场机会
    • 政府对群体定序的积极态度
    • 介绍基于次世代定序的临床研究的新基因panel
  • 市场挑战
    • 诊断测试的准确性问题和标准化问题

波特五力：驾驭基因面板市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解基因面板市场的外部影响

外部宏观环境因素对基因面板市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解基因面板市场的竞争状况

对基因面板市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵基因面板市场厂商绩效评估

FPNV定位矩阵是评估基因面板市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，绘製基因面板市场的成功之路

基因面板市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 遗传疾病和罕见疾病迅速增加
      • 对个人化药物的需求不断增长
      • 多基因面板测试在肿瘤学实践中的快速采用
    • 抑制因素
      • 确保遗传资料安全的相关问题
    • 机会
      • 政府首选的团体定序方法
      • 介绍基于次世代定序的用于临床研究的新基因组
    • 任务
      • 诊断测试的准确性问题和标准化问题
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章基因面板市场：依技术分类

  • 微阵列
  • 次世代定序
  • 聚合酵素链锁反应

第七章 基因组市场：副产品

  • 检测套组
  • 测试服务

第八章基因面板市场：依应用分类

  • 癌症诊断
  • 遗传疾病
  • 感染疾病
  • 药物基因组学

第九章 基因组市场：依最终使用者分类

  • 学术研究所
  • 医院和诊断实验室
  • 製药和生物技术公司

第十章 美洲基因组市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太基因体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲基因组市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Arizona Oncology
  • ARUP Laboratories
  • Becton, Dickinson, and Company
  • BGI Group
  • Bio-Rad Laboratories, Inc.
  • Blueprint Genetics Oy by Quest Diagnostics
  • CENTOGENE NV
  • Cepheid by Danaher Corporation
  • Eurofins Genomics LLC
  • Everything Genetic Ltd.
  • Fulgent Genetics
  • Genewiz by Azenta Life Sciences
  • Guardant Health, Inc.
  • Illumina Inc.
  • myGenomics
  • Myriad Genetic Laboratories Inc.
  • NanoString Technologies, Inc.
  • Natera, Inc.
  • Novogene Co, Ltd.
  • PrimBio Research Institute
  • Qiagen NV
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience
Product Code: MRR-FF012EDC38AC

The Gene Panel Market was valued at USD 3.11 billion in 2023, expected to reach USD 3.41 billion in 2024, and is projected to grow at a CAGR of 9.99%, to USD 6.06 billion by 2030.

Gene panels are collections of genes examined simultaneously using next-generation sequencing technologies. They are crucial for identifying genetic mutations linked to various diseases, enabling precise and personalized medicine. The necessity of gene panels arises from their capacity to offer rapid, comprehensive genetic insights, improving diagnostic accuracy and treatment personalization. Applications span multiple domains, including oncology, where they facilitate mutation detection for targeted therapies, and genetic disorders for early diagnosis. In end-use scenarios, gene panels are vital in clinical diagnostics, research institutions, and hospitals, particularly within oncology and rare disease sectors.

KEY MARKET STATISTICS
Base Year [2023] USD 3.11 billion
Estimated Year [2024] USD 3.41 billion
Forecast Year [2030] USD 6.06 billion
CAGR (%) 9.99%

Market growth is influenced by rising demand for personalized medicine, advancements in sequencing technologies, and increasing research funding. The growing incidence of genetic disorders and cancer augments demand for effective diagnostic tools like gene panels. The latest opportunities lie in developments of panels for more extensive gene detection and enhancements in accuracy and speed. There is a burgeoning interest in direct-to-consumer genetic testing as awareness of personal genomics rises. Recommendations for businesses include investing in expanding the scope of gene panels to encompass more rare diseases and collaborating with healthcare providers to integrate testing into regular practice.

However, challenges such as high costs of testing, complex data interpretation, and regulatory landscapes hamper market growth. The intricate nature of genetic data necessitates skilled personnel, and the variability in regulatory standards across regions can impede global market expansion. Innovative areas for business growth include developing cost-effective, comprehensive panels and employing artificial intelligence for data analysis to streamline interpretation processes. Companies can focus on creating panels that target not only disease-causing mutations but also pharmacogenomics for better drug responses, reinforcing the trend towards personalized medicine. Moreover, expanding partnerships with biotech firms and academic research institutions could propel advancements and market expansion effectively. Adapting to and anticipating regulatory changes proactively can also provide a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Panel Market

The Gene Panel Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surging prevalence of genetic disorders and rare disease
    • Growing need for the personalized medicines
    • Rapid adoption of multi-gene panel testing in oncology practice
  • Market Restraints
    • Issues in ensuring the security of genetic data
  • Market Opportunities
    • Favorable government initiatives for population sequencing
    • Introduction of new gene panels based on next-generation sequencing for clinical research
  • Market Challenges
    • Accuracy concerns and standardization issues in diagnostic testing

Porter's Five Forces: A Strategic Tool for Navigating the Gene Panel Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Panel Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Panel Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Panel Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Panel Market

A detailed market share analysis in the Gene Panel Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Panel Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Panel Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Panel Market

A strategic analysis of the Gene Panel Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Panel Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Arizona Oncology, ARUP Laboratories, Becton, Dickinson, and Company, BGI Group, Bio-Rad Laboratories, Inc., Blueprint Genetics Oy by Quest Diagnostics, CENTOGENE N.V., Cepheid by Danaher Corporation, Eurofins Genomics LLC, Everything Genetic Ltd., Fulgent Genetics, Genewiz by Azenta Life Sciences, Guardant Health, Inc., Illumina Inc., myGenomics, Myriad Genetic Laboratories Inc., NanoString Technologies, Inc., Natera, Inc., Novogene Co, Ltd., PrimBio Research Institute, Qiagen N.V., Thermo Fisher Scientific Inc., and Twist Bioscience.

Market Segmentation & Coverage

This research report categorizes the Gene Panel Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technique, market is studied across Microarray, Next-Generation Sequencing, and Polymerase Chain Reaction.
  • Based on Product, market is studied across Test Kits and Testing Services.
  • Based on Application, market is studied across Cancer Diagnostics, Genetic Disorders, Infectious Diseases, and Pharmacogenomics.
  • Based on End-User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surging prevalence of genetic disorders and rare disease
      • 5.1.1.2. Growing need for the personalized medicines
      • 5.1.1.3. Rapid adoption of multi-gene panel testing in oncology practice
    • 5.1.2. Restraints
      • 5.1.2.1. Issues in ensuring the security of genetic data
    • 5.1.3. Opportunities
      • 5.1.3.1. Favorable government initiatives for population sequencing
      • 5.1.3.2. Introduction of new gene panels based on next-generation sequencing for clinical research
    • 5.1.4. Challenges
      • 5.1.4.1. Accuracy concerns and standardization issues in diagnostic testing
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Panel Market, by Technique

  • 6.1. Introduction
  • 6.2. Microarray
  • 6.3. Next-Generation Sequencing
  • 6.4. Polymerase Chain Reaction

7. Gene Panel Market, by Product

  • 7.1. Introduction
  • 7.2. Test Kits
  • 7.3. Testing Services

8. Gene Panel Market, by Application

  • 8.1. Introduction
  • 8.2. Cancer Diagnostics
  • 8.3. Genetic Disorders
  • 8.4. Infectious Diseases
  • 8.5. Pharmacogenomics

9. Gene Panel Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Hospital & Diagnostic Laboratories
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Gene Panel Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Gene Panel Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Gene Panel Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Arizona Oncology
  • 3. ARUP Laboratories
  • 4. Becton, Dickinson, and Company
  • 5. BGI Group
  • 6. Bio-Rad Laboratories, Inc.
  • 7. Blueprint Genetics Oy by Quest Diagnostics
  • 8. CENTOGENE N.V.
  • 9. Cepheid by Danaher Corporation
  • 10. Eurofins Genomics LLC
  • 11. Everything Genetic Ltd.
  • 12. Fulgent Genetics
  • 13. Genewiz by Azenta Life Sciences
  • 14. Guardant Health, Inc.
  • 15. Illumina Inc.
  • 16. myGenomics
  • 17. Myriad Genetic Laboratories Inc.
  • 18. NanoString Technologies, Inc.
  • 19. Natera, Inc.
  • 20. Novogene Co, Ltd.
  • 21. PrimBio Research Institute
  • 22. Qiagen N.V.
  • 23. Thermo Fisher Scientific Inc.
  • 24. Twist Bioscience

LIST OF FIGURES

  • FIGURE 1. GENE PANEL MARKET RESEARCH PROCESS
  • FIGURE 2. GENE PANEL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE PANEL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE PANEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE PANEL MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE PANEL MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE PANEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE PANEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENE PANEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENE PANEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES GENE PANEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES GENE PANEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. GENE PANEL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. GENE PANEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE PANEL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE PANEL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE PANEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE PANEL MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE PANEL MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE PANEL MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE PANEL MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE PANEL MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE PANEL MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE PANEL MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE PANEL MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE PANEL MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE PANEL MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENE PANEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENE PANEL MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENE PANEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES GENE PANEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. GENE PANEL MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. GENE PANEL MARKET, FPNV POSITIONING MATRIX, 2023